Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2014 1
2016 1
2017 2
2018 2
2020 2
2021 1
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study.
Martín-García D, García-Aranda M, Varela-Moreno E, Padilla-Ruiz M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Téllez T, García-Gutiérrez S, González N, Rivero A, Sarasqueta C, Perestelo-Pérez L, Castells X, Quintana JM, Sala M, Redondo M; REDISSEC/CAMISS Group. Martín-García D, et al. Eur J Surg Oncol. 2025 Aug;51(8):110280. doi: 10.1016/j.ejso.2025.110280. Epub 2025 Jun 24. Eur J Surg Oncol. 2025. PMID: 40618651 Free article.
Sox2 promotes tamoxifen resistance in breast cancer cells.
Piva M, Domenici G, Iriondo O, Rábano M, Simões BM, Comaills V, Barredo I, López-Ruiz JA, Zabalza I, Kypta R, Vivanco Md. Piva M, et al. Among authors: barredo i. EMBO Mol Med. 2014 Jan;6(1):66-79. doi: 10.1002/emmm.201303411. EMBO Mol Med. 2014. PMID: 24178749 Free PMC article.
Factors that Influence Treatment Delay for Patients with Breast Cancer.
Padilla-Ruiz M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Téllez T, García-Gutiérrez S, González N, Rivero A, Sarasqueta C, Serrano-Aguilar P, Castells X, Quintana JM, Sala M, Redondo M; REDISSEC-CaMISS Group; Castells X, Comas M, Domingo L, Macià F, Roman M, Romero A, Sala M, Barata T, de la Lastra ID, de la Vega M, Bare M, Torà N, Ferrer J, Castanyer F, Carmona C, García S, Martín M, González N, Orive M, Valverde MA, Saez A, Barredo I, de Toro M, Ferreiro J, Quintana JM, Pérez J, Rivero A, Valcárcel C, Padilla M, Redondo M, Téllez T, Zarcos I, Churruca C, Perales A, Recio J, Ruiz I, Sarasqueta C, Urraca JM, Michelena MJ, Moreno J, Mallabiabarrena G, Cobos P, Otero B, Gorostiaga J, Troya I. Padilla-Ruiz M, et al. Among authors: barredo i. Ann Surg Oncol. 2021 Jul;28(7):3714-3721. doi: 10.1245/s10434-020-09409-2. Epub 2020 Nov 27. Ann Surg Oncol. 2021. PMID: 33247362
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
Miret C, Orive M, Sala M, García-Gutiérrez S, Sarasqueta C, Legarreta MJ, Redondo M, Rivero A, Castells X, Quintana JM, Garin O, Ferrer M; REDISSEC-CaMISS Group. Miret C, et al. Qual Life Res. 2024 May;33(5):1433-1435. doi: 10.1007/s11136-024-03628-w. Qual Life Res. 2024. PMID: 38457055 Free PMC article. No abstract available.
12 results